ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

China Resources Pharmaceutical Group Limited clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 70 studies whose lead sponsor is China Resources Pharmaceutical Group Limited or one of 8 companies grouped under it. 24 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 8 registry names, not the registry’s. See them and correct one ↓

Compare China Resources Pharmaceutical Group with Boehringer Ingelheim and AstraZeneca →

Pipeline: 11 programs

Each counted once: 11 with a study China Resources Pharmaceutical Group Limited leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 5 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of China Resources Pharmaceutical Group Limited’s own registered studies; China Resources Pharmaceutical Group Limited’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs China Resources Pharmaceutical Group Limited’s studies test, most open studies first — 9 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

9 of China Resources Pharmaceutical Group Limited’s studies under way reach primary completion within a year, 5 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 7D
  3. 1J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 9 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 70 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now2434%Recruiting 15 · Not yet recruiting 9
  • Completed3043%
  • Stopped early23%Withdrawn 1 · Terminated 1
  • Status unknown or other1420%Status unknown 13 · No longer available 1

Phase

  • Phase 228
  • Phase 320
  • Phase 119
  • Phase 44

Where

  • China54
  • United States13
  • Georgia1
  • Russian Federation1
  • Belarus1
  • Mexico1

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 1023
  18. 24
  19. 25
  20. 626

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to China Resources Pharmaceutical Group Limited.

  • Tasly Pharmaceutical Group Co., Ltd
    Acquired — became part of China Resources Pharmaceutical Group Limited, Mar 27, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    32 studies →
  • Tasly Pharmaceuticals, Inc.
    Acquired — became part of China Resources Pharmaceutical Group Limited, Mar 27, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    17 studies →
  • Tasly Biopharmaceuticals Co., Ltd.
    Acquired — became part of China Resources Pharmaceutical Group Limited, Mar 27, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Tasly Tianjin Biopharmaceutical Co., Ltd.
    Acquired — became part of China Resources Pharmaceutical Group Limited, Mar 27, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • China Resources Zizhu Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • China Resources Biopharmaceutical Co., Ltd
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
    Acquired — became part of China Resources Pharmaceutical Group Limited, Mar 27, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 50 of 70. Browse all 70 →